Tuesday, April 4, 2017

Future Care Nursing Homes

Future Care is a Pasadena-based, family-owned operator of 14 skilled nursing and rehabilitation facilities in Maryland. Its first one, in Pineview, opened in 1986, and the company now employs about 3,800 people. Future Care provides dialysis, short-stay rehabilitation, ventilator care and skilled nursing facilities. Their locations include: Canton Harbor in Baltimore Charles Village in Baltimore Cherrywood in Reisterstown Chesapeake in Arnold Cold Spring in Baltimore Courtland in Baltimore Good Samaritan in Baltimore Homewood in Baltimore Irvington in Baltimore Lochearn in Baltimore Northpoint in Baltimore Old Court in Baltimore Pineview in Clinton Sandtown in Baltimore. Eleven of the facilities are on Medicare’s Nursing Home Compare website. For most of them, their overall rating is “above average”; one is “much above average”; three are “average”; and one (Chesapeake in Arnold) is ranked as “below average.” The company’s website states its facilities are involved in a “Hospitalizations” campaign. Its reported goal is to “prevent our residents from the trauma and risks associated with hospitalization when an acute condition can safely be managed in the facility.” The benefits listed include the fact that residents avoid the hassle of a trip to the hospital while staff cares for residents on-site. While residents can face problems while being cared for in a hospital, there are conditions and situations which Future Care is not equipped to handle. Failure to transfer a resident because of a serious medical problem that gets worse in a nursing home can be a basis for a negligence lawsuit. One factor motivating Future Care may be the fact that they don’t receive payment for care if a resident is elsewhere, so there’s a financial incentive to keep ill residents in the facility as long as possible. Virtually any nursing home can be the scene of neglect or abuse.

The post Future Care Nursing Homes appeared first on The Law Offices of Roger S. Weinberg, IIc.

No comments:

Post a Comment